S Wessler. Show Affiliations »
Abstract
Mesh： See more » Acute DiseaseAnticoagulants/adverse effectsAnticoagulants/therapeutic useArteriovenous Shunt, Surgical/adverse effectsAtrial Fibrillation/prevention & controlCoumarins/therapeutic useExtracorporeal Circulation/adverse effectsFemaleHeart, Artificial/adverse effectsHemorrhage/chemically inducedHeparin/therapeutic useHumansIntracranial Embolism and Thrombosis/prevention & controlMaleMicrocirculationMyocardial Infarction/prevention & controlPlatelet AdhesivenessProthrombin TimePulmonary Embolism/prevention & controlRheumatic Heart Disease/prevention & controlThrombophlebitis/epidemiologyThrombophlebitis/mortalityThrombophlebitis/prevention & controlUnited States
Substances： See more » AnticoagulantsCoumarinsHeparin
Year: 1974 PMID： 4406270 DOI： 10.1001/jama.228.6.757
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272